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Abstract
Background: The larval stages of the tapeworms Echinocoocus granulosus and Echinococcus multilocularis are the
causative agents of human cystic echinococcosis (CE) and human alveolar echinococcosis (AE), respectively. Both CE
and AE are chronic diseases characterised by long asymptomatic periods of many years. However, early diagnosis of
the disease is important if treatment and management of echinococcosis patients are to be successful.
Methods: A previously developed rapid diagnostic test (RDT) for the differential detection of CE and AE was evaluated
under field conditions with finger prick blood samples taken from 1502 people living in the Ganzi Tibetan Autonomous
Prefecture, China, a region with a high prevalence for both forms of human echinococcosis. The results were compared
with simultaneously obtained abdominal ultrasonographic scans of the individuals.
Results: Using the ultrasonography as the gold standard, sensitivity and specificity, and the diagnostic accuracy of the
RDT were determined to be greater than 94% for both CE and AE. For CE cases, high detection rates (95.6–98.8%) were
found with patients having active cysts while lower detection rates (40.0–68.8%) were obtained with patients having
transient or inactive cysts. In contrast, detection rates in AE patients were independent of the lesion type. The positive
likelihood ratio of the RDT for CE and AE was greater than 20 and thus fairly high, indicating that a patient with a
positive test result has a high probability of having echinococcosis.
Conclusions: The results suggest that our previously developed RDT is suitable as a screening tool for the early
detection of human echinococcosis in endemic areas.
Keywords: Cystic echinococcosis, Alveolar echinococcosis, Echinococcus granulosus, Echinococcus multilocularis,
Abdominal ultrasound image examination, Rapid diagnostic test
Background
Human echinococcosis is one of the world’s most serious
parasitic zoonosis caused by larval stages of cestodes be-
longing to the genus Echinococcus (family Taeniidae).
Among them, cystic echinococcosis (CE) caused by E. gran-
ulosus and alveolar echinococcosis (AE) caused by E. multi-
locularis are the most common forms of the disease [1, 2].
Both CE and AE mainly affect the liver, causing chronic dis-
ease. Human echinococcosis is not only a serious medical
condition but also a social and economic problem for vul-
nerable populations [3]. CE has a worldwide distribution
whereas AE occurs mainly in the northern hemisphere in
higher latitudes. A further complication is that the two
forms of human echinococcosis are co-endemic in many
areas of the world [4–8].
Currently, diagnosis of human echinococcosis is based
predominantly on imaging techniques. Ultrasound is the
commonly used method for diagnosis of both CE and
AE. Using ultrasound, the location, number and size of
cysts or lesions can be identified, although in a time-
consuming way. However, small-sized lesions may not
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be detected by ultrasonography and the technique is not
particularly suitable for the diagnosis of pulmonary echi-
nococcosis as the air in the lung and the sternum inter-
fere with the imaging. Different traditional serological
tests based on antibody detection are widely used for the
diagnosis of human echinococcosis to complement
imaging-based examination, especially when imaging
features are unclear [9–13]. However, imaging and trad-
itional immunological tests require well-equipped facil-
ities and well-trained staff.
Rapid diagnostic tests (RDTs) such as immunochroma-
tographic tests are extremely easy to apply; they are rapid,
field-portable and do not need special laboratory equip-
ment, and therefore, are particularly useful in resource-
limited settings. Several reports have been published de-
scribing the performance of commercial and experimental
RDTs for the diagnosis of echinococcosis [14–18]. With
the exception of the dot immunogold filtration assay
(DIGFA) developed by Feng et al. [17], these RDTs cannot
be used for differential diagnose of CE and AE. We have
developed an immunochromatographic tests for simultan-
eous diagnosis of AE and CE that showed excellent diag-
nostic performance in laboratory evaluation [19]. This
RDT device has been recently certificated by the Chinese
FDA and is commercially available.
The aim of the present work was to evaluate the effect-
iveness of our previously developed RDT for the detection
of CE and AE under field conditions. As study site, the
Ganzi Tibetan Autonomous Prefecture was chosen be-
cause the eastern Tibetan plateau has the highest preva-
lence of human echinococcosis worldwide and both CE
and AE are co-endemic in this region [20–25].
Methods
Study area
The study was conducted in Ganzi Tibetan Autonomous
Prefecture (27°58' to 34°20'N, 97°22' to 102°29'E) from
May to October in 2016. The region is situated in the
west of the Sichuan Province on the Tibetan Plateau.
More than three-quarters (78.4%) of the population in
the area are Tibetans.
Study subjects
Outpatients with clinical suspicion of echinococcosis
(abdominal pain or discomfort, poor appetite, marasmus,
etc.) were presented voluntarily at the local hospital or
at the Centre for Disease Control in the Ganzi Prefec-
ture. Patients who previously had surgery for echinococ-
cosis or who were under medication for echinococcosis
were excluded from the study.
Ultrasonography and immunodiagnostic test
Ultrasound examinations and immunodiagnostic tests were
carried out by different members of staff at the same time
and their results were blinded to each other. Before initi-
ation of the study, a training course in ultrasound examin-
ation and in the use of the RDT device, and in
interpretation and recording of results was provided.
Study participants were given an abdominal ultrasono-
graphic scan using a portable ultrasound machine (GE
LOGIQ Book XP, General Electric, Boston, USA). The
recorded ultrasound images were read by two experi-
enced sonographers and graded as CE, AE, CE plus AE,
other lesions or normal. The classification of CE cysts
and AE lesions were based on stage-specific ultrasound
images [26–28]. It should be noted that AE lesions were
graded according to the US classification because it of-
fers better value in field screenings as it provides infor-
mation about lesion size.
The RDT device (cystic echinococcosis and/or al-
veolar echinococcosis antibody gold immunochro-
matographic assay test kit; Shanghai Xinjier
Biotechnology Co. Ltd., Shanghai, China) used in
this study was previously developed by our study
group [19] and certificated by the Chinese FDA
under the registration no. 20163400065. This RDT
uses crude hydatid cyst fluid (HCF) and a recom-
binant 18 kDa protein (rEm18) as antigens for the
detection of E. granulosus and E. multilocularis
antibodies in serum samples, respectively [19].
Whole blood samples were collected from each par-
ticipant by finger prick and 20 μl was immediately
applied to the RDT device. Results were read after
15 min and recorded according the product’s in-
struction as follows: only control line turned pink =
negative for CE and AE; control line and test line 1
(HCF antigen) turned pink = positive for CE; con-
trol line and test line 2 (rEM18 antigen) turned
pink as well as control line, test line 1 (HCF anti-
gen) and test line 2 (rEM18 antigen) turned pink =
positive for AE. As for most AE cases as well as for
CE/AE co-infections both test lines appear pink (i.e.
the test does not discriminate between E. multilocu-
laris and E. granulosus/E. multilocularis infections),
AE single infections and CE/AE co-infections were
confirmed by ultrasonography.
The results of ultrasound examinations and immuno-
diagnostic tests were eventually matched by an inde-
pendent expert.
Data analysis
Diagnostic parameters (sensitivity, specificity, positive
and negative predictive values, positive and negative like-
lihood ratios, and accuracy) for the performance of the
RDT were calculated from a 2 × 2 table using the ultra-
sound imaging results as a gold standard. The parame-
ters were computed using the online diagnostic test
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evaluation calculator MEDCALC (https://www.medcalc.
org/calc/diagnostic_test.php).
Results
A total of 1502 people with suspicion of echinococcosis
living in the Ganzi Tibetan Autonomous Prefecture were
simultaneously examined by abdominal ultrasonography
and tested for the presence of echinococcosis antibodies
using our RDT device. Echinococcal cysts and lesions
were found in 440 patients by ultrasonography while no
evidence of an echinococcosis infection was detected in
the remaining 1062 individuals. Of the echinococcosis
patients, 275 were diagnosed with CE and 165 with AE
(Table 1). Cysts and lesions of all echinococcosis cases
were exclusively found in the liver. However, as only ab-
dominal ultrasonography was performed, it remained
unknown whether any of the apparently uninfected indi-
viduals had echinococcal cysts elsewhere in their bodies
(e.g. lungs). No dual infection with both CE and AE was
found in any patient. It should also be mentioned that
none of the patients were found to be infected with
other helminths or other pathogens.
According to the criteria for the classification of ultra-
sound images of echinocoocsis [26–28], about three-
quarters (73.5%) of CE cases were determined to have
CE1- or CE2-type cysts while about one-fifth (22.2%)
had CE3-type cysts and only a few (~ 4%) had CE4- or
CE5-type cysts (Table 1). Of the 275 CE cases, 259
tested positive for the presence of CE antibodies with
our RDT (Table 1). Interestingly, considerably more pa-
tients with active CE1-, CE2- and CE3a-type cysts
showed a positive reaction (95.6–98.8%) than patients
with transient/inactive CE3b-, CE4- and CE5-type cysts
(40.0–68.8%) (Table 1). For the patient group with active
cysts, the overall positive percentage was 98.0% (242 out
of 247) with a 95% confidence interval of 97.7–98.2%.
For the patient group with transient/inactive cysts, the
overall positive percentage was 60.7% (17 out of 28) with
a 95% confidence interval of 57.1–69.7%. Two non-
overlapping confidence intervals provide strong evidence
that the proportion positive was indeed different in the
two groups and not due to chance.
Of the 165 AE cases, the majority of patients (72%)
had AE2- or AE3-type lesions (Table 1). About a quarter
of patients (23.6%) had AE2f- and AE3f-type lesions that
were grouped together as cases with AEf-type lesions
(Table 1). Only a few cases (~ 4%) were determined to
have AE1-type lesions (Table 1). Of the 165 patients with
AE lesions, 161 tested positive for the presence of AE
antibodies with our RDT (Table 1). In contrast to CE
cases, for AE cases no obvious dependency was observed
between lesion type and positive antibody response as
most patients with any AE lesion showed a positive reac-
tion (87.5–100%) (Table 1).
Of the 1062 individuals whose abdominal ultrasound
was negative for the presence of echinococcosis cysts or
lesions, between 3–4% gave a positive reaction with our
RDT for the apparent presence of E. granulosus and/or E.
multilocularis antibodies (Table 1). These patients are
under observation for the development of echinococcosis.
Using the results of the ultrasound examination as a
gold standard, the diagnostic parameters for the per-
formance of our RDT under field conditions were calcu-
lated. Sensitivity and specificity of the RDT for the
detection of both CE and AE were quite high (> 94%)
(Table 2). The positive predictive values were significantly
lower than the negative predictive values (especially for
AE) (Table 2) indicating that the RDT in the current epi-
demiological situation of echinococcosis in the study area
was somewhat better in correctly identifying negative re-
sults. However, the high positive likelihood ratios (> 20)
and the low negative likelihood ratios (< 0.1) (Table 2)
provide strong evidence that our RDT can be used to diag-
nose both CE and AE. The accuracy of our RDT was very
similar for detection of both CE and AE (Table 2), and
with values of ≥ 96%, the probability that patients were
correctly identified was quite high.
Discussion
Human echinococcosis is considered a neglected zoo-
notic disease [29] and can be categorised as an ‘infec-
tious diseases of poverty’ [30]. Diagnosis of the disease is
mainly based on ultrasound imaging examination and
conventional immunological tests. In underserved rural
endemic areas, there is usually a general lack of facilities
and an absence of well-trained health-workers restricting
Table 1 Results of ultrasound imaging and RDT of 1502 people













CE 275 259 (94.2) 0 (0) 16 (6.8)
CE1 86 85 (98.8) 0 (0) 1 (1.1)
CE2 116 114 (98.3) 0 (0) 2 (1.7)
CE3a 45 43 (95.6) 0 (0) 2 (4.4)
CE3b 16 11 (68.8) 0 (0) 5 (31.2)
CE4 7 4 (57.1) 0 (0) 3 (42.9)
CE5 5 2 (40.0) 0 (0) 3 (60.0)
AE 165 0 (0) 161 (97.6) 4 (2.4)
AE1 7 0 (0) 6 (85.7) 1 (14.3)
AE2 70 0 (0) 68 (97.1) 2 (2.9)
AE3 49 0 (0) 48 (98.0) 1 (2.0)
AEfa 39 0 (0) 39 (100) 0 (0)
Negative 1062 31 (2.9) 45 (4.2) 986 (92.8)
aIncludes AE2f and AE3f cases
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the diagnosis of echinococcosis by imaging and sero-
logical techniques. An ideal diagnostic test should be
sensitive, specific, suitable for the use in the field and
easy to perform and interpret. RDTs such as immuno-
chromatographic tests are usually extremely easy to
apply. In addition, they are rapid, field-proven, inexpen-
sive, and particularly useful in resource-poor settings.
Several commercial and experimental RDTs for the diag-
nosis of CE or AE have been developed [14–16], but
studies evaluating these devices under field conditions
are very limited [17, 31]. Therefore, we previously devel-
oped an RDT which can detect simultaneously CE and AE
with high sensitivity and specificity [19]. The results of the
present study showed that our RDT can diagnose infec-
tions with E. granulosus and E. multilocularis in > 94% in
patients with hepatic CE cysts and in > 97% with hepatic
AE lesions, respectively, when tested under the current
epidemiological situation of echinococcosis in the Ganzi
region. It is worth noting that sensitivity, specificity and
accuracy of our RDT determined under field conditions
were comparable to those previously established under la-
boratory conditions [19].
Likelihood ratios are independent of the prevalence of
a disease in a population and, therefore, are very useful
measures for the diagnostic accuracy of a diagnostic test
[32]. The high positive likelihood ratios of our RDT con-
firm that a patient with a positive test result has a high
probability of being infected with E. granulosus or E.
multilocularis. On the other hand, the low negative like-
lihood ratios of our RDT indicate a low risk of error
when excluding an Echinococcus infection in individuals
with a negative test result. These findings indicate that
our RDT has fairly high sensitivity and accuracy in the
detection of both CE and AE.
Although very high detection rates were found for pa-
tients with CE1-, CE2- and CE3a-type cysts, consider-
ably lower detection rates were obtained with patients
having CE3b-, CE4- and CE5-type cysts. This outcome
may be due to the fact that the latter cyst types are tran-
sient (CE3b-type cyst) or inactive with calcifications
(CE4- and CE5-type cysts) [26] releasing only minimal
amounts of or even no antigen [33]. As a consequence,
the patient’s immune response would decrease over time
and lower amounts of antibodies would be produced
after a while. In contrast, high detection rates were
found for patients with any type of AE lesions. However,
patients with AE1 lesions usually show weak immune re-
sponses [28]. The high seropositive rate in AE1 patients
observed in this study may be due to their small number
that might have biased the results.
Quite a few individuals (76 in total) with no ultra-
sound evidence of abdominal CE cysts or AE lesions
gave a positive reaction with our RDT. However, the cor-
responding percentage proportions were relatively small
in these groups (2.9 and 4.3% for apparent CE and AE
detection, respectively) and close to the false positive
rates previously determined for the test with healthy do-
nors under laboratory conditions (3.3 and 1.7% for ap-
parent CE and AE detection, respectively [19]). Another
explanation could be that these positive-tested subjects
had cysts or lesions that were too small to be detectable
by the imaging technique used. This may also be an in-
dication for the limitation of ultrasonography in the de-
tection of echinococcosis during the early stages of the
infection. Alternatively, these individuals may have had
cysts or lesions in other organs, with the lungs being the
second most primarily infected organ in about 11–14%
of CE patients [34, 36] while primary extra-hepatic loca-
tions in AE patients are rare [35, 36] (note that our RDT
can identify patients with pulmonary CE cysts although
with lower reactivity [19]). In a previous study we found
pulmonary echinococcosis in 4.9% of CE patients and
none in AE patients [19]. Other possibilities for the posi-
tive test results may include serological cross-reactivity
with related tapeworms or abortive Echinococcus infec-
tions. Therefore, it is necessary to carry out long-term
follow-up examinations of individuals who show positive
echinococcosis serology but have no cysts or lesions.
The main purpose of this study was to evaluate the
performance of our ITC device under clinical field con-
ditions. Therefore, individuals with clinical suspicion of
Table 2 Diagnostic performance of RDT in the detection of CE
and AE
Diagnostic parameter CE (95% CI) AE (95% CI)
True positive (tp) 258 161
True negative (tn) 1031a 1017b
False positive (fp) 31 45
False negative (fn) 16 4
Sensitivityc (%) 94.2 (90.7–96.6) 97.5 (93.9–99.3)
Specificityd (%) 97.1 (95.9–98.0) 95.8 (94.3–96.9)
Positive likelihood ratioe 32.3 (22.8–45.7) 23.0 (17.3–30.7)
Negative likelihood ratiof 0.06 (0.04–0.10) 0.03 (0.01–0.07)
Positive predictive valueg (%) 89.3 (85.5–92.2) 78.2 (72.8–82.7)
Negative predictive valueh (%) 98.5 (97.6–99.0) 99.6 (99.0–99.9)
Accuracyi (%) 96.5 (95.3–97.4) 96.0 (94.8–97.0)
Abbreviation: CI confidence interval
aTrue negative = total no. of negative minus no. of CE positive (1062
minus 31)
bTrue negative = total no. of negative minus no. of AE positive (1062
minus 45)
cSensitivity = tptpþfn × 100
dSpecificity = tntnþfp × 100
ePositive likelihood ratio = sensitivity1−specificity
fNegative likelihood ratio = 1−sensitivityspecificity
gPositive predictive value = tptpþfp
hNegative predictive value = tntnþfn
iAccuracy = tpþtntpþtnþfpþfn
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echinococcosis were selected as study subjects. This
could have resulted in some bias as the prevalence of
echinococcosis in this subgroup was 34% (20.57% for CE
and 13.45% for AE) which is far from the real prevalence
in the population. For example, Li et al. reported a
prevalence of 5.95% (1.94% for CE, 4.01% for AE and 0.
00% for dual infection) in the Ganzi prefecture during
the period 2001–2008 [20].
Human CE and AE are chronic diseases with a
spectrum of clinical manifestations ranging from asymp-
tomatic to serious, even life-threatening conditions [1].
Usually, most cases of echinococcosis in humans are di-
agnosed accidentally [8]. However, early diagnosis of the
disease can greatly improve the management and treat-
ment of patients. In order to accomplish this, an effect-
ive screening test is needed. Imaging methods are
suitable for mass screening in underserved rural en-
demic areas, but they require well-trained staff and are
time-consuming [37]. However, our RTD is a simple de-
vice that requires only 20 μl of whole blood [19]. The test
takes less than 20 minutes and the result is displayed visu-
ally [19]. Moreover, with this device, testing can be carried
out while patients are waiting and, therefore, the whole
procedure is more convenient for patients than conven-
tional immunological assays or imaging techniques. In
conclusion, we suggest that the best method for early de-
tection of Echinococcus infections would be preliminary
mass screening programmes for at-risk populations in en-
demic areas using an RDT followed by confirmation of
positive cases using imaging techniques. We think that
our RDT fulfils the criteria for an echinococcosis screen-
ing test: the device is easy to use, quick and cheap, and
has a high sensitivity, i.e. it essentially indicates suspicion
of the disease that warrants confirmation. Importantly,
our RDT can distinguish between both CE and AE that
should help to guide subsequent diagnosis.
Conclusions
In this study, we have shown that our previously devel-
oped RDT performed well under clinical field conditions
and is a useful screening and complementary tool for the
detection of echinococcosis in humans. Only patients with
a positive result would need confirmation of their infec-
tion status by ultrasound imaging technique. However, it
remains to be shown whether the RDT will perform
equally well in mass screening studies (under real field
conditions including all inhabitants of an endemic area).
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